Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2021-09-29 Regulatory Filings
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Explanatory Note to the 2021 Annual Report 1 page 9
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 30 September 2021 providing an explanatory note regarding differences between the unaudited preliminary final results and the audited annual report for the fiscal year. It references the Annual Report but does not contain the full report itself, only a brief explanation of differences in financial figures. The document length is short (1390 characters), and it serves as an announcement clarifying financial results rather than presenting comprehensive financial statements or detailed analysis. According to the 'Menu vs Meal' rule, this is an announcement related to a report rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-09-29 English
Annual Report to shareholders 53 pages 1.1MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report for the Year Ended 30 June 2021' and contains detailed sections typical of an annual report, including Chairman's Letter, Corporate Governance Statement, Directors' Report, Auditor's Independence Declaration, full financial statements (profit or loss, financial position, changes in equity, cash flows), notes to the financial statements, Directors' Declaration, and Independent Auditor's Report. The content includes comprehensive financial data, operational review, governance information, and audit details for the full fiscal year ending 30 June 2021. The document length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2021
2021-09-29 English
Appendix 4G and Corporate Governance Statement 29 pages 605.9KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a form used by ASX-listed entities to confirm compliance with corporate governance disclosure requirements. The document includes a checklist of governance principles and recommendations, indicating whether the entity has followed them and where disclosures can be found, often pointing to the corporate governance statement on the company's website or annual report. The document explicitly states it is not a substitute for the corporate governance statement and is lodged alongside the annual report. It is a regulatory filing required by the ASX to verify governance disclosures but does not itself contain the full governance report or financial data. The document length (15,000 characters) is substantial but primarily consists of a compliance checklist and references to other documents rather than substantive financial or management reports. Therefore, this document fits best under Regulatory Filings (RNS) as a compliance and disclosure verification filing rather than a full governance report or annual report.
2021-09-29 English
Preliminary Final Report 35 pages 618.3KB
Annual Report Classification · 95% confidence The document is an Appendix 4E and Preliminary Financial Report for the year ended 30 June 2021, submitted to the Australian Securities Exchange (ASX). It contains detailed financial statements including profit or loss, balance sheet, cash flows, and notes to the financial statements. The report covers a full fiscal year and includes comprehensive financial data and management commentary. The Appendix 4E is a regulatory filing used in Australia for preliminary final reports, which is equivalent to an annual report but preliminary and unaudited at the time of release. Given the detailed financial content and the full-year period, this document fits the definition of an Annual Report (10-K equivalent). It is not merely an announcement or certification but contains substantive financial data and analysis for the full fiscal year. FY 2021
2021-08-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 439.0KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'REPORT FOR THE QUARTER ENDED 30 JUNE 2021' and contains detailed financial and operational information for the quarter, including cash flow statements, revenue, losses, and operational highlights. It includes an Appendix 4C Quarterly cash flow report, which is a regulatory requirement for quarterly reporting under ASX Listing Rules. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content focuses on quarterly financial results and operational updates, consistent with an Interim / Quarterly Report. There is no indication that this is an annual report, audit report, earnings release, or other specific filing types. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q4 2021
2021-07-21 English
Appendix 4C - quarterly 8 pages 433.9KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'REPORT FOR THE QUARTER ENDED 31 MARCH 2021' and contains detailed financial and operational information for the quarter, including cash flow statements, sales revenue, losses, and cash balances. It includes an Appendix 4C Quarterly cash flow report, which is a regulatory requirement for entities listed on the ASX, providing detailed cash flow data for the quarter. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content focuses on quarterly financial results and operational highlights, consistent with an Interim / Quarterly Report. There is no indication that this is an Annual Report, Earnings Release, or other filing types. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2021
2021-04-29 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.